ANGARANO, GIOACCHINO
 Distribuzione geografica
Continente #
NA - Nord America 4.142
EU - Europa 3.446
AS - Asia 1.826
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 5
SA - Sud America 3
AF - Africa 2
Totale 9.436
Nazione #
US - Stati Uniti d'America 4.135
CN - Cina 1.279
IE - Irlanda 1.248
UA - Ucraina 1.007
SE - Svezia 542
TR - Turchia 306
FI - Finlandia 220
IN - India 167
DE - Germania 140
GB - Regno Unito 113
IT - Italia 84
SG - Singapore 69
BE - Belgio 29
CZ - Repubblica Ceca 20
RU - Federazione Russa 20
FR - Francia 14
EU - Europa 12
CA - Canada 7
RO - Romania 4
AU - Australia 3
CL - Cile 3
JP - Giappone 3
NZ - Nuova Zelanda 2
AT - Austria 1
CH - Svizzera 1
CM - Camerun 1
ES - Italia 1
GN - Guinea 1
HK - Hong Kong 1
MK - Macedonia 1
NL - Olanda 1
PH - Filippine 1
Totale 9.436
Città #
Dublin 1.247
Chandler 754
Jacksonville 715
Dearborn 625
Nanjing 408
Nyköping 255
Nanchang 163
Wilmington 153
San Mateo 146
Princeton 145
Ann Arbor 132
Beijing 124
Boardman 110
Helsinki 78
Ashburn 70
Kunming 67
Hebei 60
Jiaxing 57
Shenyang 55
Tianjin 55
Woodbridge 50
Singapore 45
Changsha 38
Des Moines 32
Hangzhou 31
Hilden 31
Brussels 29
Lanzhou 27
Los Angeles 22
Changchun 20
Stevenage 19
Zhengzhou 19
Guangzhou 18
Jinan 17
Ningbo 17
Brno 15
Taizhou 15
Auburn Hills 11
Shanghai 11
Norwalk 10
Hefei 7
Saint Petersburg 7
Fuzhou 6
Orange 5
New York 4
Olomouc 4
Timisoara 4
Bari 3
Bologna 3
Cogoleto 3
Jinhua 3
Kocaeli 3
Milan 3
Piombino 3
Pune 3
Augusta 2
Baotou 2
Brisbane 2
Caserta 2
Florence 2
Foggia 2
Gioia Del Colle 2
Haikou 2
Hanover 2
Pavia 2
Pisa 2
Redwood City 2
Sacramento 2
Wuhan 2
Auckland 1
Baltimore 1
Bethesda 1
Bitritto 1
Boise 1
Brooklyn 1
Catania 1
Central 1
Chongqing 1
Cutrofiano 1
Dagupan 1
Ercolano 1
Giovinazzo 1
Gloucester 1
Greenwich 1
Guidonia 1
Hamilton 1
Heze 1
Houston 1
Indianapolis 1
Kobe 1
Lambeth 1
Lanciano 1
Lausanne 1
Marano Di Napoli 1
Melbourne 1
Menlo Park 1
Monticello Brianza 1
Nanning 1
Nantong 1
Noci 1
Totale 6.016
Nome #
PREVALEAT STUDY (PREMATURE VASCULAR LESIONS AND ANTIRETROVIRAL THERAPY). A COMPARATIVE STUDY BETWEEN PATIENTS TREATED WITH PI-INCLUDING REGIMENS VS NNRTI-INCLUDING REGIMENS. 110
Distribuzione dell'anti-HAV in un campione di popolazione pugliese 95
Fattori di contagiosita' nell'epidemiologia dell'epatite virale di tipo B 89
Ulteriore espansione dell'epidemia di HCV in pazienti emodializzati: valutazione clinico-epidemiologica alla luce dei tests diagnostici di II generazione 88
Mutations in the reverse transcriptase gene of HIV-1 from subjects after d4T/ddI dual therapy 87
Circulating immune complexes in HBsAg carriers with chronic hepatitis and other extra-hepatic manifestations 87
Zidovudine prophylaxis after accidental exposure to HIV: the Italian experience 85
Cerebral SPECT with 99mTc-HM-PAO and Magnetic Resonance in Drug Abusers and AIDS patients with Dementia 85
Studio epidemiologico della epatite cronica in relazione alla infezione da virus B dell'epatite 84
Associazione tra tubercolosi ed infezione da HIV: programma per uno studio multicentrico 83
Epidemiologia della epatite A in Puglia 83
A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection 81
Cell-mediated immunity and immunosuppressive therapy in HbsAg-positive chronic active hepatitis 81
Long-term administration of Inosine-Pranobex (INPX) in anti-HIV asymptomatic carriers. Preliminary results of a controlled study 81
Interazioni virus-ospite nell'infezione cronica da HBV 81
Il sistema HBeAg/anti-HBe nella infezione cronica da virus B dell'epatite 81
Complicanze neurologiche di tipo encefalitico in corso di Rosolia 81
Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with human immunodeficiency virus type 1 80
Tuberculosis and Human Immunodeficiency Virus infection in Italy 80
Possible significance of antibodies to Legionella pneumophila in HIV-1 infected patients with acute respiratory illness 80
Impact of mutations conferring reduced susceptibility to lamivudine on the response to antiretroviral therapy 80
L'anticorpo antinucleare (anti-HBc) e patologia acuta e cronica del fegato da virus B dell'epatite 79
Drug-resistant tuberculosis in human immunodeficiency virus infected persons in Italy. The Italian Drug-Resistant Tuberculosis Study Group 78
Drug susceptibility patterns in 195 european patients de novo infected with drug resistant virus: implications for post-exposure prophylaxis 78
Ulcero-necrotic Herpes Simplex in a male patient affected by AIDS 78
Diagnosi sierologica dell'epatite acuta da virus A. Messa a punto e valutazione di tre metodiche per la determinazione delle IgM specifiche anti-HAV 78
A randomized double-blind study of virological, clinical and safety effects of a combination of stavudine and didanosine versus zidovudine and didanosine in treatment-naive HIV-infected individuals 77
L'anti-HBc nella diagnostica della infezione da virus B dell'epatite 77
Survival of Zidovudine-treated patients with AIDS compared with that of contemporary untreated patients 76
AIDS 75
I marcatori di infettività e diffusione della infezione da virus B dell'epatite in una unità dialitica 75
Longitudinal analysis of the 90K glycoprotein in the Italian HIV-seroconversion study: temporal trend and predictability of the maturity of HIV infection 75
Hepatitis B virus markers, alpha-fetoprotein and survival in fulminant viral hepatitis 74
Storia naturale dell'infezione da HIV nelle donne 74
La determinazione radioimmunologica delle IgM virus-specifiche nella diagnosi rapida di epatite virale di tipo A 74
I sistemi HBsAg/anti-HBs ed eAg/anti-e nella epatite cronica 73
Real Versus Virtual Phenotype to Guide Treatment in Heavily Pretreated Patients: 48-Week Follow-Up of the Genotipo-Fenotipo di Resistenza (GenPheRex) Trial 73
Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men 73
Valore prognostico dell'alfa-fetoproteina nella epatite acuta fulminante 73
Prevalence of HBV genotypes in South American immigrants affected by HBV-related chronic active hepatitis. 73
Risk of developing AIDS in newly seropositive intravenous drug abusers 72
Serological merkers predicting tuberculosis in human immunodeficiency virus-infected patients 72
Drug injection in jugular veins: a new risk factor for vascular diseases in HIV-infected patients? 72
Adherence as a gender issue: psychosocial factors influencing antiretroviral adherence in HIV-seropositive women 72
Valutazione di un test immunoenzimatico (ELISA) per la determinazione di un sistema Ag/Ab correlato all’epatite non-A,non-B post-trasfusionale 72
Su due casi di coinfezione Leishmania-HIV osservati in Puglia 71
Markers di repicazione virale (HBeAg) e attivita' DNA polimerasica nell'uremico cronico in trattamento emodialitico periodico 71
Indagine sieroepidemiologica sulla infezione da HIV in soggetti osservati presso la Clinica Dermatologica di Bari 71
Prevalence of cryptosporidiosis in HIV-infected patients with diarrhoeal illness 71
Dosaggio radioimmunologico dell’HAV e delle IgA anti-HAV nelle feci di pazienti con epatite acuta di tipo A 70
Studio di una epidemia di epatite virale 70
Prevalence of pol Gene Mutations in a Cohort of Antiretroviral-Naive Patients: Correlation with HIV RNA and CD4 Count at the Time of Genotypic Testing 70
Infectivity markers in HbsAg chronic carriers and intrafamilial spread of hepatitis B virus infection 69
Chlamydia pneumoniae: a new opportunistic infectious agent in AIDS? 69
Comportamento dei linfociti T teofillino-sensibili nell'epatite da virus A, B, non-A,non-B. I.Aspetti metodologici 69
La candidosi orale recidivante e persistente nei pazienti con infezione da HIV-1. Schemi di trattamento 68
Archivio computerizzato per la gestione ambulatoriale ed in day hospital dei pazienti anti-HIV positivi 68
L’epatite post-trasfusionale non-A.non-B. Indagine sierologica in 85 soggetti con epatite acuta associata a trasfusione di sangue 68
Sintesi intratecale di IgG in corso di infezioni da HIV 68
La diagnosi precoce di encefalite da Herpes Simplex Virus 68
Alterazioni oftalmoscopiche e fluorangiografiche in pazienti affetti da AIDS 68
Clinica delle Micobatteriosi nei pazienti immunodepressi 67
Gli immunocomplessi nelle epatiti croniche 67
Le infezioni da Herpes virus 67
Superinfezione da virus non-A,non-B in portatori cronici di HBsAg. Aspetti clinici e virologici 67
Trichosporon beigelii infection in AIDS patients undergoing antifungal prophylaxis: report of two cases 66
Lesions retiniennes chez des patients VIH seropositifs 65
Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naive Patients 65
The Calculated Genetic Barrier for Antiretroviral Drug Resistance Substitutions Is Largely Similar for Different HIV-1 Subtypes 65
Cerebral lesions in two AIDS patients: the possible role of Mycobacterium kansasii 64
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005). 64
HBsAg loss is enough to discontinue long-term nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B patients in real practice 64
Seconda infezione varicellosa in adulto affetto da AIDS 64
Parkinsonism in a patient with AIDS and cerebral opportunistic granulomatous lesions 63
Ocular manifestations in HIV-seropositive patients 63
Topical thymopentin therapy in HIV positive patients with recurrent oral candidiasis: a pilot study 63
Disease progression and early predictors of AIDS in HIV-seroconverted injecting drug users 63
Mutations at Codons 10 and 36 of Protease Region in Absence of Primary Mutations May Correlate with Virological Outcome in Naive Patients Starting a PI-Containing HAART Regimen 63
Current problems in treating tuberculosis in Italian HIV-infected patients 63
Epatite non-A,non-B 63
Transmission of zidovudine-resistant HIV-1 through heterosexual contacts 63
Comparison of three enzyme-linked immunosorbent assays suitable for the detection of antibodies to rotaviruses in epidemiological studies 62
Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group 62
Diffuse necrotic hepatic lesions due to Visceral Leishmaniasis in AIDS 62
I "Long-Term Non-Progressor" negli studi di coorte sull'infezione da HIV 62
A cyanobacterium-like body found in the stools of an HIV+ patient with diarrhoea 62
Rapporti tra immunocomplessi circolanti e virus B nelle epatiti croniche 62
La tubercolosi farmacoresistente 62
Cyclospora in AIDS patients: not always an agent of diarrhoic syndrome 62
Persistence of e antigen as prognostic marker in acute hepatitis B 61
Efficacy of protease inhibitor-based antiretroviral therapy in severe HIV-associated thrombocytopenia unresponsive to AZT 61
Early abnormalities in the antibody response against Mycobacterium tuberculosis in the human immundeficiency virus infection 61
Premature vascular lesions in HIV-positive patients: a clockwork bomb that will explode? 61
Efficacy of itraconazole in treating AIDS-associated infections due to Candida krusei 60
I centri dialisi: un modello epidemiologico di diffusione del virus epatico C 60
Chronic cryptococcal meningitis in an intravenous drug addict without evidence of infection by HIV-1,2 in southern Italy 59
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy 59
Markers of response to zidovudine monotherapy among treated HIV seroconverters 59
Chlamydia pneumoniae respiratory infections among patients infected with the human immunodeficiency virus 59
Influence of gender, age, and transmission category on the progression from HIV seroconversion to AIDS 59
Totale 7.128
Categoria #
all - tutte 40.247
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.247


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.732 0 263 58 55 280 354 330 23 174 21 165 9
2020/20211.067 145 10 149 3 148 130 153 11 147 161 7 3
2021/2022702 152 4 2 6 63 21 25 70 85 59 51 164
2022/20233.153 222 19 101 263 255 380 2 184 1.556 24 67 80
2023/2024344 98 22 17 8 27 40 5 38 8 0 6 75
2024/202585 69 16 0 0 0 0 0 0 0 0 0 0
Totale 9.504